# A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers

> **NCT01537497** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 31 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** PF-05175157
- **DRUG:** PF-05175157
- **DRUG:** PF-05175157
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01537497
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2012-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01537497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01537497, "A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01537497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*